Skip to Main Content

Author Details

Maria Mitzi Brentani
Sao Paulo University
1964
161
31
PMIDPaper TitleJournal TitlePublished Year
31817155Stromal Cell Signature Associated with Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.Cells2019
29854292Somatic mutations in early onset luminal breast cancer.Oncotarget2018
30214726Immunoexpression of claudins 4 and 7 among invasive breast carcinoma subtypes: A large diagnostic study using tissue microarray.Mol Clin Oncol2018
28355358Breast-conserving surgery in locally advanced breast cancer submitted to neoadjuvant chemotherapy. Safety and effectiveness based on ipsilateral breast tumor recurrence and long-term follow-up.Clinics (Sao Paulo)2017
26808127Breast Carcinoma-associated Fibroblasts Share Similar Biomarker Profiles in Matched Lymph Node Metastasis.Appl Immunohistochem Mol Morphol2016
27547399The role of oncoplastic breast conserving treatment for locally advanced breast tumors. A matching case-control study.Ann Med Surg (Lond)2016
27152840A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer.PLoS One2016
26942683The effects of urban particulate matter on the nasal epithelium by gender: An experimental study in mice.Environ Pollut2016
26137258MYC is expressed in the stromal and epithelial cells of primary breast carcinoma and paired nodal metastases.Mol Clin Oncol2015
26603012Somatic mutations in breast and serous ovarian cancer young patients: a systematic review and meta-analysis.Rev Assoc Med Bras (1992)2015
26640797Docosahexaenoic Acid Modulates a HER2-Associated Lipogenic Phenotype, Induces Apoptosis, and Increases Trastuzumab Action in HER2-Overexpressing Breast Carcinoma Cells.Biomed Res Int2015
26142737Specific upregulation of RHOA and RAC1 in cancer-associated fibroblasts found at primary tumor and lymph node metastatic sites in breast cancer.Tumour Biol2015
23194083TGF-β1 expression in wound healing is acutely affected by experimental malnutrition and early enteral feeding.Int Wound J2014
25249769Transcriptional profile of fibroblasts obtained from the primary site, lymph node and bone marrow of breast cancer patients.Genet Mol Biol2014
25006670MicroRNAs discriminate familial from sporadic non-BRCA1/2 breast carcinoma arising in patients ⿤35 years.PLoS One2014
24587767Estrogen-responsive genes overlap with triiodothyronine-responsive genes in a breast carcinoma cell line.ScientificWorldJournal2014
23623780Calcitriol supplementation effects on Ki67 expression and transcriptional profile of breast cancer specimens from post-menopausal patients.Clin Nutr2014
22749134Lipid raft disruption by docosahexaenoic acid induces apoptosis in transformed human mammary luminal epithelial cells harboring HER-2 overexpression.J Nutr Biochem2013
24229053Markers of breast cancer stromal fibroblasts in the primary tumour site associated with lymph node metastasis: a systematic review including our case series.Biosci Rep2013
23636418Breast cancer tissue slices as a model for evaluation of response to rapamycin.Cell Tissue Res2013
23469205Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil.PLoS One2013
23497279Transcriptional effects of 1,25 dihydroxyvitamin D(3) physiological and supra-physiological concentrations in breast cancer organotypic culture.BMC Cancer2013
22939885Differences in transcriptional effects of 1α,25 dihydroxyvitamin D3 on fibroblasts associated to breast carcinomas and from paired normal breast tissues.J Steroid Biochem Mol Biol2013
21956537Prognostic significance of CD24 and claudin-7 immunoexpression in ductal invasive breast cancer.Oncol Rep2012
22790468[Thyroid hormone profile in breast cancer patients in postmenopause].Arq Bras Endocrinol Metabol2012
22496928Down-regulation of ANAPC13 and CLTCL1: Early Events in the Progression of Preinvasive Ductal Carcinoma of the Breast.Transl Oncol2012
22489321Tumor microenvironmental genomic alterations in juvenile nasopharyngeal angiofibroma.Head Neck2012
22084168Gene expression profile in response to doxorubicin-rapamycin combined treatment of HER-2-overexpressing human mammary epithelial cell lines.Mol Cancer Ther2012
21985131Four-gene expression model predictive of lymph node metastases in oral squamous cell carcinoma.Acta Oncol2012
20820980Influence of the interaction between nodal fibroblast and breast cancer cells on gene expression.Tumour Biol2011
21691702Transcriptional profile and response to neoadjuvante chemotherapy in breast cancer.Rev Assoc Med Bras (1992)2011
21371080Role of Fos-related antigen 1 in the progression and prognosis of ductal breast carcinoma.Histopathology2011
20043090Concomitant expression of epithelial-mesenchymal transition biomarkers in breast ductal carcinoma: association with progression.Oncol Rep2010
22993619Markers of vascular differentiation, proliferation and tissue remodeling in juvenile nasopharyngeal angiofibromas.Exp Ther Med2010
21103787Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancer patients.Braz J Med Biol Res2010
20692600Short-term specialized enteral diet fails to attenuate malnutrition impairment of experimental open wound acute healing.Nutrition2010
20462450Smad2 and Smad6 as predictors of overall survival in oral squamous cell carcinoma patients.Mol Cancer2010
20307664Human breast tumor slices: a model for identification of vitamin D regulated genes in the tumor microenvironment.J Steroid Biochem Mol Biol2010
19913910The role of p38 mitogen-activated protein kinase in serum-induced leukemia inhibitory factor secretion by bone marrow stromal cells from pediatric myelodysplastic syndromes.Leuk Res2010
19530251Reciprocal changes in gene expression profiles of cocultured breast epithelial cells and primary fibroblasts.Int J Cancer2009
19893985Expression of E-cadherin, Snail and Hakai in epithelial cells isolated from the primary tumor and from peritumoral tissue of invasive ductal breast carcinomas.Braz J Med Biol Res2009
19942988Influence of estradiol and triiodothyronine on breast cancer cell lines proliferation and expression of estrogen and thyroid hormone receptors.Arq Bras Endocrinol Metabol2009
19724859Gene expression profile of residual breast cancer after doxorubicin and cyclophosphamide neoadjuvant chemotherapy.Oncol Rep2009
18228521Genetic alterations in juvenile nasopharyngeal angiofibromas.Head Neck2008
19199269Expression of heterochromatin protein 1 in the primary tumor of breast cancer patients in the presence or absence of occult metastatic cells in the bone marrow.Int J Biol Markers2008
19246968Tamoxifen inhibits transforming growth factor-alpha gene expression in human breast carcinoma samples treated with triiodothyronine.J Endocrinol Invest2008
18473934Gene expression profiles in breast cancer to identify estrogen receptor target genes.Mini Rev Med Chem2008
18534255Expression of vitamin D receptor mRNA in the hippocampal formation of rats submitted to a model of temporal lobe epilepsy induced by pilocarpine.Brain Res Bull2008
18601734Tumor slices as a model to evaluate doxorubicin in vitro treatment and expression of trios of genes PRSS11, MTSS1, CLPTM1 and PRSS11, MTSS1, SMYD2 in canine mammary gland cancer.Acta Vet Scand2008
17211533Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.Breast Cancer Res Treat2007
  • 1 - 50 of 161

Recommended Authors

Westmead Institute for Medical Research, The University of Sydney
Career Start Year 1993
Number of shared co-authors 0
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 1
Fred Hutchinson Cancer Research Center
Career Start Year 1991
Number of shared co-authors 0
Central Finland Hospital Nova
Career Start Year 1990
Number of shared co-authors 0
Institutet of Bioinformatics, University Hospital of Munster, University of Munster
Career Start Year 1990
Number of shared co-authors 0
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 0
Radboud University Medical Centre
Career Start Year 1987
Number of shared co-authors 1
Washington University School of Medicine
Career Start Year 1987
Number of shared co-authors 0
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 0
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
University of California
Career Start Year 1984
Number of shared co-authors 0
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 0
Universita degli Studi di Milano
Career Start Year 1984
Number of shared co-authors 1
Universidad de Alcala
Career Start Year 1983
Number of shared co-authors 1
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 0
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 0
Pathologisches Institut, Universitatsklinikum Heidelberg
Career Start Year 1981
Number of shared co-authors 0
University of Oxford
Career Start Year 1981
Number of shared co-authors 2
Garvan Institute of Medical Research
Career Start Year 1980
Number of shared co-authors 0
The Norwegian Radium Hospital, Oslo University Hospital
Career Start Year 1980
Number of shared co-authors 0
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1979
Number of shared co-authors 2
Blokhin N.N. National Medical Research Center of Oncology
Career Start Year 1979
Number of shared co-authors 0
Universite de Paris-Cite
Career Start Year 1979
Number of shared co-authors 0
Norwich Medical School, University of East Anglia
Career Start Year 1978
Number of shared co-authors 2
The Institute of Cancer Research
Career Start Year 1978
Number of shared co-authors 1
Buck Institute for Research on Aging
Career Start Year 1977
Number of shared co-authors 0
University of Toronto
Career Start Year 1977
Number of shared co-authors 1
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 1973
Number of shared co-authors 0
Institute for Cancer Research, Oslo University Hospital
Career Start Year 1972
Number of shared co-authors 0

Collaborators

School of Medicine of Sao Paulo University
Co-authored papers 42
Center for Translational Oncology, Cancer Institute of the State of Sao Paulo - ICESP
Co-authored papers 34
Sao Paulo University
Co-authored papers 18
Brazilian Institute of Cancer Control (IBCC)
Co-authored papers 17
Instituto Brasileiro de Controle do Cancer
Co-authored papers 12
AC Camargo Cancer Center
Co-authored papers 11
Instituto do Cancer do Estado de Sao Paulo, Universidade de Sao Paulo
Co-authored papers 9
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Co-authored papers 5
Faculdade de Medicina, Universidade de Sao Paulo
Co-authored papers 3
Instituto Brasileiro de Controle do Cancer
Co-authored papers 2
University of Hull
Co-authored papers 2
A.C.Camargo Cancer Center
Co-authored papers 2
Universidade Federal de Santa Maria
Co-authored papers 2
Ludwig Institute for Cancer Research Ltd.
Co-authored papers 1
Rutgers Cancer Institute of New Jersey
Co-authored papers 1
Co-authored papers 1
Instituto Rene Rachou
Co-authored papers 1
Instituto Do Cancer Do Estado de Sao Paulo
Co-authored papers 1
Universidade Federal do Rio Grande do Norte
Co-authored papers 1
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Hospital Alemao Oswaldo Cruz
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Center for Cell-Based Therapy (CTC)
Co-authored papers 1
Heart Institute (InCor), University of Sao Paulo School of Medicine
Co-authored papers 1
University of Sao Paulo
Co-authored papers 1
Ribeirao Preto Medical School - University of Sao Paulo
Co-authored papers 1